August 2026– date –
-
Chemically Defined Media and Automation Key to Overcoming Raw Material Variability in Autologous Cell Therapy Manufacturing
BioProcess International USA Overview Addressing raw material variability in autologous adoptive cell therapies necessitates the adoption of chemically defined media, standardized handling, automation, and well-characterized unit operati... -
Biologics and GLP-1 Agonists Drive Acceleration of Automation and Digitization in Fill-Finish Manufacturing
BioProcess Online USA Overview The rapid rise of biologics—including antibody-drug conjugates (ADCs), cell & gene therapies, and mRNA products—and GLP-1 receptor agonists is accelerating the evolution of fill-finish manufacturing pro... -
Scire Science Launches SBIO-420 Benchtop Bioreactor, Strengthening India’s Biotech Ecosystem with Indigenous Technology
Scire Science (LinkedIn) India Overview Scire Science has announced the launch of the SBIO-420 Benchtop Magnetic Stirring Glass Bioreactor, an indigenously developed product designed to bolster India's biotechnology ecosystem. The SBIO-4... -
ENEA’s Novel Rotating Drum Bioreactor Dramatically Boosts Monoclonal Antibody Production Yields
ENEA - Agenzia nazionale (Facebook) Italy Overview Researchers at the Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA) have engineered an innovative rotating drum bioreactor that significan... -
In Vivo CAR T-Cell Therapy KLN-1010 Achieves 100% MRD Negativity in Multiple Myeloma Phase 1 Trial, Presented at ASCO/EHA 2026
International Myeloma Foundation USA Overview At the 2026 ASCO and EHA meetings, groundbreaking results for KLN-1010, an in vivo CAR T-cell therapy eliminating the need for ex vivo T-cell harvest, were highlighted. The clinical trial in ... -
CSPC Pharmaceutical and AstraZeneca Form Joint Venture for AI-Driven GMP Biologics Manufacturing Facility in China
BioPharm International China Overview CSPC Pharmaceutical Group and AstraZeneca have signed a joint venture agreement to construct a next-generation biopharmaceutical manufacturing facility in Shijiazhuang, China. This facility aims to i... -
CellFiber and Tidewave Bio Partner to Evaluate 3D Cell Culture Platform for Scalable Manufacturing of Next-Gen Cell Immunotherapies
BioProcess International Global Overview CellFiber and Tidewave Bio have initiated a joint Proof of Concept (PoC) to evaluate CellFiber's 3D cell culture platform for scalable manufacturing of Tidewave's next-generation cell immunotherap... -
Human Methacryloyl Platelet Lysate Hydrogels Emerge as Robust Xeno-Free Platform for 3D Cell Culture and Tissue Engineering
PMC (National Library of Medicine) USA Overview Novel xeno-free human methacryloyl platelet lysate (hPLMA) hydrogels have been developed, demonstrating robust and reproducible performance in 3D cell culture and tissue engineering applica... -
AI Drives Bioprocess Optimization, Enhancing Titer, Rate, and Yield (TRY) in Pharmaceutical Manufacturing
Corvic AI (Facebook) Global Overview Artificial intelligence (AI) is emerging as a pivotal technology transforming pharmaceutical manufacturing by dramatically boosting efficiency and quality in bioprocess development. Machine learning m... -
Japan Establishes Rigorous Regulatory Framework for Stem Cell and Regenerative Medicine under ASRM
PlacidWay Japan Overview Japan has implemented a stringent regulatory framework for stem cell therapy and regenerative medicine, based on the Act on the Safety of Regenerative Medicine (ASRM). The Ministry of Health, Labour and Welfare (...
